Oxford Financial Group LTD Aspira Women'S Health Inc. Transaction History

Oxford Financial Group LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$5.9 - $9.13 $438,257 - $678,185	-74,281 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.54 - $4.56 $9,006 - $16,169	3,546 Added 5.01%	74,281 $229,000
Q2 2020 Aug 05, 2020	BUY	$0.78 - $5.25 $55,173 - $371,358	70,735 New	70,735 $272,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

Stay updated on Oxford Financial Group LTD with notifications on news.